Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down – Should You Sell?

Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) gapped down prior to trading on Tuesday . The stock had previously closed at $17.85, but opened at $17.41. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $17.00, with a volume of 61,506 shares trading hands.

Analyst Upgrades and Downgrades

TLX has been the topic of a number of analyst reports. UBS Group raised their price target on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a “buy” rating in a research note on Monday, January 27th. William Blair reissued an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Wednesday.

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

The company’s fifty day moving average is $17.38.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.